Skip to main content

Melanoma Clinical Trials

Review the melanoma clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 76-100 of 239

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
Status: Active
Location: 2 locations
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
Status: Active
Location: 2 locations
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Status: Active
Location: 2 locations
A Beta-only IL-2 ImmunoTherapY Study
Status: Active
Location: 2 locations
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
Status: Active
Location: 3 locations
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
Status: Active
Location: 2 locations
Stereotactic Body Radiation Therapy with Nivolumab and BMS986253 for the Treatment of Multiple Metastases in Patients with Advanced Solid Tumors
Status: Active
Location: 2 locations
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab
Status: Active
Location: 2 locations
Comparison of In-Home versus In-Clinic Administration of Subcutaneous Nivolumab through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
Comparing Length of Treatment with Immunotherapy in Patients with Advanced Solid Tumors
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Immunotherapy and Cryoablation of an Enlarging Tumor for the Treatment of Unresectable Metastatic Melanoma
Status: Active
Location: Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Atorvastatin for Preventing Disease Metastasis in Patients with Resected High-Risk Stage IIA, IIB, or IIIA Melanoma
Status: Active
Location: OHSU Knight Cancer Institute, Portland, Oregon
Cyclophosphamide with Pembrolizumab in Treating Checkpoint Inhibitor Refractory Stage III or IV Melanoma
Status: Active
Location: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Zimberelimab and Domvanalimab for the Treatment of Relapsed or Refractory Melanoma
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Tebentafusp for the Treatment of HLA-A*0201 Positive, Metastatic Uveal Melanoma with Integrated Circulating Tumor DNA Biomarker, TARGET-tebe Trial
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Cyclophosphamide, Fludarabine, Tumor Infiltrating Lymphocytes, and Aldesleukin in Treating Patients with Metastatic Uveal Melanoma
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Olaparib in Combination with Pembrolizumab for the Treatment of Metastatic Uveal Melanoma
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Axitinib and Ipilimumab for the Treatment of Advanced Melanoma
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Nivolumab in Combination with Relatlimab in Treating Patients with Active Melanoma Brain Metastases
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Melphalan via Percutaneous Hepatic Perfusion followed by Tebentafusp for the Treatment of Uveal Melanoma Metastatic to the Liver
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Neoadjuvant Anti-PD-L1 Immunotherapy for the Treatment of Advanced Melanoma
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida